Search All News
A new study, lead by Dr. Kevin Gardner, highlights a prognostic biomarker called Kaiso that may provide some insight into the biological reasons for racial disparities in breast cancer.
Source:Journal of Clinical Pathways
Expanded genomic panel testing was clinically impactful in most patients with high-risk cancer, yet payers reimbursed only 10.75% of the charge on average, if reimbursed at all, new study found.
Findings provide new insight into the link between seizures and tumor progression; can help develop improved diagnostics and treatments for deadly form of brain cancer
- January 16, 2020
In this study, the authors reported on a single-institution experience on 3-year prospective PSCPC regarding risk of malignancy (ROM) and the overall risk of malignancy (OROM).
Source:HICCC NewsSeptember 4, 2019
Piero Dalerba, MD is one of the six inaugural Velocity fellows, whose innovative research projects to solve cancer are being funded by the money raised from the Velocity ride.
Source:CUMC NewsroomJuly 12, 2019
Piero Dalerba and Teresa M. Palomero Vazquez of Pathology share the award with four other Columbia cancer researchers
- May 24, 2019
Swarnali Acharyya has been named a 2019 Schaefer Research Scholar for her study on identifying the mechanisms of brain metastasis.
Source:Wiley Online LibraryMarch 8, 2019
Fusobacterium nucleatum, a Gram‐negative oral anaerobe, is a significant contributor to colorectal cancer.
- January 3, 2018
Pathology and Cell Biology faculty Antonio Iavarone and Anna Lasorella co-authored study about gene fusion effect on cellular activity and its relation to some cancer featured in Nature.
- January 2, 2018
We are excited to welcome Dr. Kevin Gardner as Senior Vice Chair of Department of Pathology and Cell Biology and Professor of Pathology and Cell Biology at CUMC.